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Abstract. Secl2p is an integral membrane protein re-
quired in vivo and in vitro for the formation of trans-
port vesicles generated from the ER. Vesicle budding
and protein transport from ER membranes containing
normal levels of Secl2p is inhibited in vitro by addi-
tion of microsomes isolated from a Sec12p
overproducing strain . Inhibition is attributable to titra-
tion of a limiting cytosolic protein. This limitation is
G
NETic analysis has identified four yeast genes that
are required for the formation of transport vesicles
derived from the ER: SEC12 SEC13 SEC16 and
SEC23(Kaiser and Schekman, 1990). In vitro reconstitution
of ER-Golgi transport vesicle formation also showed a re-
quirement for Secl2p and Sec23p (Rexach and Schekman,
1991) . Cell fractionation and DNA sequence analysis have
shown that Secl2p is an integral membrane protein, and
Sec23p, Secl6p, and Secl3p are either cytosolic or periph-
eral membrane proteins (Nakano et al., 1988 ; Hicke and
Schekman, 1989; Kaiser, C., and N. Pryer, unpublished
data) . Interactions observed among the genesencoding these
proteins suggest that they could act in concert or form a mul-
tisubunit complex possibly associating with the ER mem-
brane via Secl2p (Kaiser and Schekman, 1990) .
Secl2p is a type II membrane glycoprotein with a 40 kD
NH2-terminal cytosolic domain that is essential for trans-
port, and a COON-terminal lumenal domain that is dispen-
sable (Nakano et al., 1988 ; d'Enfert, C., C. Barlowe, S.
Nishikawa, A. Nakano, and R. Schekman, manuscript sub-
mitted for publication) . The thermosensitive lethality associ-
ated with a mutation in the NH2-terminal domain of Secl2p
is suppressedby overproduction of Sarlp, a 21-kD GTP-bind-
ing protein (Nakano and Muramatsu, 1989) . Sarlp is itself
required for protein transport from the ER (Nakano and
Muramatsu, 1989) . Cell fractionation experiments show
Sarlp both in the cytosol and in tightassociation with a mem-
brane fraction, however overproduction increases the frac-
tion of Sarlp soluble in the cytosol (Nishikawa and Nakano,
1991). Membrane association of Sarlp is enhanced in vivo
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overcome by addition of a highly enriched fraction of
soluble Sarlp, a small GTP-binding protein, shown
previously to be essential for protein transport from
the ER and whose gene has been shown to interact
genetically with sec12. Furthermore, Sarlp binding to
isolated membranes is enhanced at elevated levels of
Secl2p. Sarlp-Secl2p interaction may regulate the ini-
tiation of vesicle budding from the ER.
by overproduction of Secl2p (d'Enfert, C., C. Barlowe, S.
Nishikawa, A. Nakano, and R. Schekman, manuscript sub-
mitted for publication). These results suggest a structural
and functional interaction of Sarlp and Secl2p.
In the course of identifying cytosolic factors that stimulate
protein transport from the ER in vitro, we observed that ad-
dition of a membrane fraction with elevated levels of Secl2p
was inhibitory, and that a limiting cytosolic factor restored
transport when provided in an enriched form . This report
describes the identification of this limiting factor as Sarlp.
Extensive purification of a functional, apparently mono-
meric soluble form of Sarlp is achieved.
Materials andMethods
Strains, Plasmids, Materials, and
GeneralMethods
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University of California,
The yeast strains used in this study were RSY607 (leu2-3,112 ura3-52
pep4::URA3 MATE) and YPH500 (ura3-52 lys2-801 ade2-101 trpl-063
his3-A200 leu2-Al MAT4; Sikorski and Hieter, 1989). Plasmids pANYI-9
(2P URA3 SEC12), pCEY5 (2w URA3 GALI-SEC12), pANY2-7 (2p URA3
SARI), pANY2-18 (CEN4-ARS1 TRP1 GALL-SARI), and pSEY8 have been
previously described (Nakano et al., 1988; d'Enfert, C., C. Barlowe, S.
Nishikawa, A. Nakano, and R. Schekman, manuscript submitted for publi-
cation; Nakano and Muramatsu, 1989; Emr et al., 1986). pCGS109 (2P
URA3 GALL-GAL10) is a gift of D. Moir (Collaborative Research, Lexing-
ton, MA). pSEC1313 (2p URA3 SEC13) and pSEC-1614 (2F+ URA3 SEC16)
were kindlyprovided by C. Kaiser(Division ofBiochemistry and Molecular
Biology, and Howard Hughes Medical Institute, University of California,
Berkeley, CA).
Yeast cells were grown in YP (2 % Bacto-peptone 1% Yeast extract broth
both from Difco Laboratories Inc., Detroit, MI) containing 2% glucose or
in MV (0.67 % yeast nitrogen base without amino acid; Difco Laboratories
Inc.) containing 2% glucose and supplemented with the appropriate amino
acids and/or0.5 % vitamin assay Casamino acids (Difco Laboratories Inc.).For induction of GALI-regulated genes, cells were first grown in MV con-
taining 2 % lactate, pH 5.5, 0.1% glucose, and then induced by transfer in
either YP 2% galactose for 20 h or MV 2 % lactate, pH 5.5, 2 % galactose
for 5 h.
Anti-Sec12p, anti-Sarlp, anti-Sec23p, anti-Kar2p, and anti-
a,1-6-man-nose antibodies have been described (Nakano et al., 1988 ; Nishikawa and
Nakano, 1991; Hicke and Schekman, 1989; Rose et al., 1989; Baker et al.,
1988). Anti-Seel3p, antiYptlp, and anti-phosphoglycerokinasewere kindly
provided by C. Kaiser, D. Baker, and J. Thorner, respectively (Division of
Biochemistry and Molecular Biology, and Howard Hughes Medical Insti-
tute, University of California, Berkeley, CA). Transfer of proteins from
SDS-PAGEgels to nitrocellulose filters (Schleicher& Schuell, Inc., Keene,
NH) was performed as described (Towbin et al. , 1979). Filters were blocked
and all incubations were conducted in 20 mM Tris-Cl, pH 7.4, 150 mM
NaCl, 0.1 % NP-40 with or without 2% non-fat dry milk. Detectionoffilter-
bound antibodies with horseradish peroxidase-conjugated goat anti-rabbit
IgG and with ECL immunoblotting reagents were performed accoi.iing to
the supplier's instructions (Amersham Corp., Arlington Heights, IL). Pro-
teinconcentrations weredetermined by the procedureof Lowry et al. (1951)
in the presence of 1% sodium dodecyl sulfate or with the Bio-Rad protein
assay (Bio-Rad Laboratories, Richmond, CA) using BSA as a standard.
Preparation ofSubcellular Fractionsfor
In Intro Assays
Subcellular fractions were prepared from wild-type cells grown in YP 2%
glucose or from transformed cells grown in YP 2% galactose (cytosol) or
MV 2% lactate, 2% galactose (cytosol, microsome, and high speed pellet
fractions). Cytosol was prepared from bead-lysed cells as described (Baker
et al., 1988) and concentrated (12-15 mg protein/ml) by centrifugation in
Centriprep-10 unit (Amicon Corp., Danvers, MA). Preparations ofmicro-
somes and high speed pellet (HSP) fractions from osmotically-lysed cells
were carried out according to Baker et al. (1990) except that glucose was
replaced by galactose during the formation of spheroplasts when fractions
were prepared from cells grown in the presence ofgalactose. Alternatively,
the high speed pellet fraction was obtained after a 100,000-g centrifugation
of a 12,000-g supernatant from a bead-lysed cell extract (Baker et al.,
1988). This HSP fraction (20 mg protein/ml) had a lower specific transport
activity but stimulated ER-Golgi transport as efficiently as an HSP fraction
derived from osmotically lysed cells.
In IntroAssays andMicrosome-dependentInhibition
'Itvo-stage in vitro transport reactions were carried out as described (Baker
et al., 1990) using35S-labeled prepro-a-factor (Baker et al., 1988), micro-
somes (10 wg protein), cytosol (110-150 pg protein); and HSP fractions
(20-40 pg protein) in a total reaction volume of50 pl. Transport conditions
were adjusted so that activity was linearly dependent upon addition of
cytosol and HSP fractions and are noted in the figure legends. Reactions
were incubated for2 h at20°C and terminated by addition of50A12% SDS
followed by heating at 95°C for 5 min. The total amount of glycosylated
pro-a-factor was quantified by precipitation with concanavalin A-Sepha-
rose; Golgi-modified forms ofpro-a-factor were quantified by precipitation
with an antiserum specific for (al-6)-linked mannose and protein A-Sepha-
rose as described (Baker et al., 1988). In these conditions, transport effi-
ciency (ratio of Golgi-modified/total glycosylated pro-a-factor) was typi-
cally 25% and was linearly dependent upon addition of cytosol and HSP
fractions.
'Ihvo-stage in vitro budding reactions werecarried out using microsomes
(2.5 Rg protein) and cytosol (470 jig protein) in a total reaction volume of
50 Al (Wuestehube, L., and R. S. Schekman, manuscript in preparation).
Reactions were incubated for 30 min at 20°C and terminated by centrifuga-
tionat 27,000g for 10 min. Thetotal reaction mixture and supernatant frac-
tion weretreated with trypsin (0.3 mg/ml, 60 min, 4°C) followed by trypsin
inhibitor (1.2 mg/ml, 10min, 4°C). Samples were heated at 95°C for 5 min
in the presence of 1% SDS and the amount ofglycosylated pro-a-factor was
quantified by precipitation with concanavalin A-Sepharose as described
(Baker et al., 1988). Efficiency of vesicle release (ratio of supernatant/total
glycosylated pro-a-factor) typically was 24% .
To test the inhibitory effects of competitor membranes, microsomes
(0.5-5 mg protein/ml) were treated first with trypsin (0.2 mg/ml, 30 min,
4°C) and then with trypsin inhibitor (0.5 mg/ml, 10 min, 4°C). Trypsin
treatment did not affect the integrity ofthe ER membranes since the luminal
protein Kar22p remained enclosed within the sedimentable material (not
shown). Various amounts of trypsin-treated membranes were added to
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cytosol and HSP fractions and the concentrations oftrypsin and trypsin in-
hibitor were adjusted accordingly. Alternatively, trypsin-treated mem-
branes were washed by centrifugation (27,000 g, 10 min) in reaction buffer
to remove soluble trypsin and trypsin inhibitor. After a 10-min incubation
on ice, microsomes containing translocated 35S-pro-a-factor were added
and the second stage of the reaction was initiated. An 80% inhibition was
reproducibly obtained with 4-5 jig of Sec12p-enriched membranes.
To test the rescueactivity ofvarious fractions, cytosol and HSP fractions
were mixed withthe appropriate amount oftrypsin-treated Sec12p-enriched
microsomes such that -80% inhibition was obtained in the absence ofany
additional component. This mixture was kept on ice for 10 min, distributed
into tubes containing the fractions to be tested, and incubated an additional
10 min on ice. Microsomes containing translocated 35S-pro-a-factor then
were added and the second stage of the reaction was conducted.
GelFiltration ofYeast Cytosols
Cytosol was prepared from YPH500(pANY2-18) as described above. A
400-Al aliquot ofcytosol (5.9 mg) in reaction buffer containing 1 mM DTT,
0.5 mM PMSF, 1 mM ATP, and 0.1 mM GTP was loaded onto a 20 ml (1.0
x 25 cm) Sephacryl S-100 HR (Pharmacia Inc., Piscataway, NJ) gel filtra-
tion column equilibrated in reaction buffer. The column was eluted in the
same bufferat ^+12 ml/h. Fractions (400 Al) were collected and total protein
and rescue activity in each fraction was determined. Fractions were
resolved by SDS-PAGE, visualized by silver stain (Morrisey, 1981), and
examined for Sarlp content by immunoblot. As a control, cytosols not
enriched in Sarlp were prepared from YPH500(pANY2-18) and YPH500-
(pCGS109), adjusted to a protein concentration of9.5 mg/ml, and fraction-
ated using the same S-100 HR gel filtration column.
SarlpMembrane BindingAssay
Trypsin-treated microsomes (20 log) were prepared as described above and
mixed with various fractions containing soluble Sarlp in a final reaction
buffer volumeof40 AI. BSA (1 mg/ml) was included whenpartially purified
Sarlp was used in order to avoid proteolysis. After a 5-min incubation at
4°C, the membrane fraction (Fig. 7, MSP) was separated from the soluble
fraction (Fig. 7, MSS) by a 25,000-g centrifugation for 10 min in a TLA
100 rotor (Beckman Instruments, Inc., Palo Alto, CA). The supernatant
fraction was then recovered and diluted with SDS-PAGE loading buffer
(5x). The pellet was washed twice with reaction buffer and resuspended
in SDS-PAGE loading buffer (lx). Both fractions were analyzed by SDS-
PAGE and inununoblotting using anti-Sarlp and anti-Sec12p antibodies as
well as several control antibodies raised against three peripheral membrane
Sec proteins (Sec23p, Yptlp, and Sec13p) and a cytosolic protein (phos-
phoglycerokinase, PGK) . Displacement of soluble Sarlp into the Sarlp-
depleted microsomal fractionwas thenassayed by comparing the Sarlp con-
tent of each fraction. Sec12p-dependent membrane binding was observed
only for Sarlp and no significant membrane binding was observed with
Sec23p, Yptlp, Sec13p, and PGK.
Results
Secl2p-enrichedMembranes Inhibit Transport
Protein transport from the ER to the Golgi apparatus has
been reconstituted with yeast membranes and cytosol (Baker
et al., 1988, 1990; Ruohola et al., 1988). In the first stage
of transport, [35S]methionine-labeled a-factor precursor is
translocated into a crude ER membrane fraction to form
core-glycosylated precursor. Transport to the Golgicomplex
is achieved in a second stage which measures the coupled ad-
dition of outer chain carbohydrate to the core-glycosylated
precursor. In the assay developed by Baker et al. (1990),
transport is stimulated by a cytosol fraction (100,000-g su-
pernatant), a particulate fraction (HSP; 100,000-g pellet),
and ATP The particulate fraction appears to provide an en-
riched source of factors that are present in limited supply in
thecytosol, ratherthan an essential membrane compartment.
Addition of a salt wash soluble fraction, obtained by extrac-
tion ofpermeabilized spheroplasts, replaced the requirement
664forHSPmaterial (Baker, D. andL . Wuestehube, unpublished
results) .
To identify cytosolic factors that interact with Secl2p, we
designed an assay in which these components become lim-
iting through titration by excess Secl2p . This was achieved
by mixing wild-type ER membranes containing 35S-core-
glycosylated pro-a-factor with nonradioactive membranes
isolated from cells transformed with a multicopy vector con-
taining the SEC12 gene . An outline of this approach is
depicted in Fig . 1 . If the inhibitory membranes consume a
specific limiting component, inhibition should be overcome
100
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Figure 2 . Secl2p-enriched membranes specifically inhibit trans-
port . Standard ER-Golgi transport reactions were carried out with
10 Fig wild-type microsomes containing translocated pro-a-factor,
110 lAg wild-type cytosol, and 20 ug wild-type HSP prepared from
osmotically lysed cells . Increasing amounts of trypsin-treated
microsomes derived from a control strain (YPH500(pCGS109) ;
YEp : :GAL) or a strain overproducing Secl2p (YPH500(pCEY5) ;
YEp : :Gal-SEC12), both of which were grown in galactose-
containing medium, were preincubated with the cytosol and the
HSP fractions for 10 min at 0°C beforemixing with the membranes
that contained pro-a-factor . The efficiency of transport for each
reaction was compared to the maximum transport efficiency ob-
tained when competitor membranes were omitted (25%) .
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by supplementing the reaction with an enriched source of
this limiting protein .
Membranes were isolated from two strains varying only
in their content of Secl2p . Wild-type (YPH500/pCGS109 ;
YEp : :GAL) and a Secl2p-overproducing strain (YPH500/
pCEY5 ; YEp ::GAL-SEC12) were grown on galactose to in-
duce maximal synthesis of Secl2p in the latter. Membranes
were isolated and treated with trypsin under conditions
where Secl2p remains intact, but ER-Golgi transport activ-
ity is inactivated (Nakano et al ., 1988 ; d'Enfert, C., unpub-
lished data) . Membranes from the transformant contained at
least 60-fold more Secl2p than preparations from wild-type
cells. Equivalent amounts ofmembrane protein from trans-
formed and untransformed cells were mixed with cytosol and
HSP fractions for 10min at 0°C, and aliquots then added to
a stage II incubation containing wild-type ER membranes
loaded with [ 35S]a-factor precursor. Transport inhibition
related to the amount of Secl2p in the overproducer mem-
brane fraction was observed (Fig . 2) . Competitor mem-
branes isolated from cells transformed with a multicopy
plasmid containing SEC12 under control ofitsown promoter
(six- to eightfold less Secl2p than the GAL-regulated SEC12)
were threefold more potent than control membranes in in-
hibiting transport (not shown) . Inhibition was proportional
to but not linearly related to the Secl2p level . Not all of the
Secl2p may be in a form capable of competing for a
transport-limiting component .
Sarlp Is Limiting in the InhibitedReaction
The model presented in Fig . 1 implies that Secl2p titrates
a limiting cytosolic component, however, Secl2p could
equally well limit a factor present in the membrane or HSP
fraction . Trypsin treatment of the Secl2p-rich membrane
should reduce the contribution of a peripheral membrane
protein that could partition between the cytosol and mem-
brane fraction. Indeed, trypsin treatment enhanced (1.5-fold)
the inhibitory potency of the competitormembrane fraction
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Figure 1. Inhibition of ER-Golgi transport
by Secl2p-enriched membranes. In vitro-
reconstituted ER-Golgi transport monitors
the transfer of core-glycosyaated 35S-labeled
pro-a-factor (dotted circle) from the endo-
plasmic reticulum to the Golgi apparatus
where it acquires outer-chain glycosylation
(solid circle) . Interaction between Secl2p
(membrane protein) and an unknown cy-
toplasmic component (solid triangle) is
thought to be necessary for the production
of a transport vesicle . Addition of Secl2p-
enriched membranes to a standard trans-
port reaction should result in a titration
of this cytoplasmic component by these
membranes and thus in an inhibition of
transport .Figure 3. Cytosol-dependent reversal of Sec12p-mediated inhibi-
tion . Cytosols prepared from RSY607 (WT) grown inYP2% glu-
cose and from YPH500(pSEY8) (YEp), YPH500(pANY2-7)
(YEp::SARI ), and YPH500(pANY2-18) (YCp ::GAL-SARI) grown
inMV 2 % lactate 2% galactose were compared for their Sarlp con-
tent and their effect on the Sec12p-dependent transport inhibition .
(A) 25 ug of each cytosol was resolved by SDS-PAGE and im-
munoblotted with anti-Sarlp antibodies . (B) Standard transport
reactions were carried out with wild-type membranes containing
translocated pro-a-factor, 150 tLg wild-type cytosol, 40 lAg wild-
type HSP prepared from bead-lysed cells, 5 jig trypsin-treated
Sec12p-enriched microsomes, and increasing amounts of cytosol
from each strain . The efficiency of transport for each reaction was
compared to the maximum transport efficiency obtained when
Sec12p-rich microsomes and additional cytosol were omitted
(23%) . Addition of Secl2p-rich microsomes alone resulted in a
81% inhibition of transport .
(not shown) . Inhibition was partially overcome by addition
of higher-than-normal levels of cytosol to incubations that
contained the membrane mixture (Fig . 3 B) .
Given the known genetic interaction between sec12 and
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SARI (Nakano and Muramatsu, 1989), we examined the
effect of cytosols prepared from strains transformed either
with a 2p, multicopy vector carrying SARI under control of
its own promoter, with a single-copy plasmid carrying SARI
under control of the more active GALI-10 promoter, or with
a control 2p. plasmid . The relative content of Sarlp in these
cytosol fractions was compared by immunoblotting with a
polyclonal antiserum (Fig. 3 A) . The 2t. SARI produced
-20-fold more, and the CEN GAL::SARI N45-fold more
Sarlp than the untransformed and control transformed
strains, as determined by densitometry oftheSDS-PAGE im-
munoblot . Significantly greater rescue of transport was ob-
served with cytosols that contained more Sarlp (Fig . 3 B) .
Although the antidote effect was proportional but not linearly
related to the level of Sarlp overproduction, other factors
may become limiting or not all of the Sarlp may be func-
tional . Other genes (SEC13, SEC16) have been associated
with SEC12 by genetic analysis (Kaiser and Schekman,
1990) . Cytosol fractions prepared from cells transformed
with multicopy vectors carrying these genes were no more
potent than control cytosol in ameliorating inhibition by
Sec12p-rich membranes, although they contained increased
amounts ofthese SEC proteins (not shown) . Thus the inhibi-
tion by excess Sec12p is overcome by Sarlp or by some factor
that is coordinately induced by overproduction of Sarlp.
To examine the specificity ofrescue by Sarlp, cytosol from
the GAL : :SARI transformant was fractionated by gel filtra-
tion on Sephacryl S-100HR . Sarlp filtered in the included
volume with a peak of immunoreactive material in fractions
30-34 (Fig . 4 A) . Rescue assays were performed by mixing
trypsin-treated Secl2p-rich membranes with a normal dose of
the cytosol and HSP fractions and aliquots of the Sephacryl
column fractions . After 10 min at0°C the mixture was added
to wild-type membranes containing pro-a-factor followed by
incubation in a stage II transport reaction . Rescue activity
fractionated coincidentally with Sarlp and was recovered in
18% yield with respect to the starting cytosol fraction . This
level of recovery is consistent with the possibility that an-
other cytosolic factor became limiting in the presence of
competitor membranes . Although Sarlp is a 21-kD protein
(Nakano and Muramatsu, 1989), the polypeptide eluted
from the Sephacryl column at the position expected of a 7.5-
kD protein . This may account for the striking separation of
Sarlp (Fig . 4 B, closed circles) from the total protein (open
circles) on this column . Indeed, SDS-PAGE of Sarlp peak
fractions ofthe Sephacryl column showed the protein highly
enriched in relation to other polypeptides (Fig. 5) . Sarlp
overproduction was insufficient to detect a difference in
SDS-PAGE comparison of cytosol fractions prepared from
untransformed and transformed cells (not shown) . Parallel
Sephacryl fractionation of cytosol from a control strain
grown on galactose showed little rescue activity (not shown)
and Sarlp was not detected in equivalent column fractions
(Fig . 5) . Sarlp appears to be directly responsible for reversal
of the inhibitory effect of excess Sec12p.
Sarlp Stimulates VesicleBudding
Although Sarlp is required for protein transport from theER
(Nakano and Muramatsu, 1989), a role in vesicle budding
or fusion has not been distinguished . We used a vesicle bud-
ding assay that detects the release of transport vesicles from
the ER to monitor the effect of Sec12p-rich membranes and
666Figure 4 . Sarlp copurifies with the activity that reverses transport
inhibition . A cytosol derived from YPH500(pANY2-18) grown in
YP2% galactose was fractionated onto a 20-ml Sephacryl S-100
HR gel filtration column . Fractions (400 td) were examined for
Sarlp content, effect on transport inhibition, and protein con-
centration . (A) Representative fractions (8 )l) were resolved by
SDS-PAGE and immunoblotted with anti-Sarlp antibodies. Un-
fractionated cytosol (20 ug) is shown as a control for Sarlp (G) . (B)
Standard transport reactions were carried out with 10 Wg wild-type
membranes, 150 1~g wild-type cytosol, 40 Wg wild-type HSP pre-
pared from bead-lysed cells, 5 hg trypsin-treated Secl2p-enriched
microsomes, and 20 p,l ofcolumn fractions . The efficiency oftrans-
port for each reaction was compared to the maximum transport
efficiency obtained when Secl2p-rich microsomes and column
fractions were omitted (14%) . Addition ofSecl2p-rich microsomes
alone resulted in an 88% inhibition oftransport . 68% of the maxi-
mum transport efficiency was recovered when 201~g ofthe unfrac-
tionated cytosol was added to an inhibited reaction . The protein
concentration in each fraction is shown . The Sephacryl S-100
column was calibrated with markers that filtered to the following
positions : void volume, blue dextran fraction 20 ; included volume,
ovalbumin (43 kD) fraction 24 ; ribonucleaseA (14 kD) fraction 30 ;
column volume, COC12 fraction 45-50 .
rescue by Sarlp. In this assay, vesicle budding from an en-
riched ER fraction is monitored by the appearance of
protease-protected core-glycosylated [35S]pro-ct-factor in a
slowly sedimenting compartment that is resolved from ER
by differential centrifugation (Wuestehube, L ., and R . S .
Schekman, manuscript in preparation) . Vesicle release is
cytosol- and energy-dependent and is retarded by GTPYS .
Released vesicles are competent for transfer of core
glycosylated pro-a-factor to a fresh supply of membranes .
Secl2p-rich membranes inhibited vesicle budding (Fig .
6) . Membranes isolated from the GAL-regulated SEC12
transformant decreased budding by 69%, whereas mem-
branes isolated from an untransformed cell decreased bud-
ding by 4% . Budding inhibition was overcome by addition
of cytosol from a Sarlp overproducing strain (restored to
75% of normal), while the same amount of cytosol from an
untransformed strain offered no rescue . Sephacryl S-100
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Figure 5 . Sarlp enrichment
by gel filtration . Cytosols
prepared from control (YPH-
500(pCGS109) ; GAL) and
Sarlp overproducing (YPH-
500(pANY2-18) ; GAL-SARI)
strains grown inYP 2% galac-
tose were fractionated on an
S-100 HR gel filtration col-
umn. Fractions corresponding
to the peak of rescue activity
obtained with the Sarlp-en-
riched cytosol were resolved
bySDS-PAGE followed by sil-
ver staining . The elution of
Sarlp is indicated .
enriched fractions of Sarlp also were active as an antidote
to inhibition of budding by Secl2p-rich membranes (not
shown) . These results suggest that Sarlp interacts with
Secl2p to facilitate the formation of transport vesicles from
the ER .
Membrane Binding ofSarlp Is Stimulated by Secl2p
Secl2p may act to sequester Sarlp by recruitment to the
membrane fraction or by inactivation of a form that remains
cytosolic. Membranes containing normal or overproduced
levels of Secl2p were used to examine recruitment of Sarlp
from a crude cytosol orof Sarlp purified on Sephacryl S-100.
Membrane fractions were treated with trypsin to remove en-
dogenous Sarlp and mixed with crude or purified Sarlp frac-
tions at 4°C . The content of Secl2p and the redistribution of
Sarlp to membranes was evaluated by immunoblotting par-
ticulate (medium speed pellet [MSP]) and soluble (medium
speed supernatant [MSSJ) fractions resolved by SDS-PAGE
(Fig . 7) . Secl2p was detected by immunoblot only in mem-
branes derived from cells transformed with a multicopy vec-
tor containing SEC12 (Fig. 7, S, lanes 2, 4, 7, and 10) ;
Secl2p was only partially sensitive to trypsin cleavage (com-
pare lane 2 with lanes 4, 7, and 10) . Untreated membranes
from the SEC12 transformant contained more endogenous
Sarlp than was found in untransformed control membranes
(Fig . 7, compare lanes 1 and 2) . This species was quantita-
tively converted by trypsin to a Sarlp fragment (Fig . 7,
Sar1A) that sedimented in the MSP fraction . Exogenous
Sarlp became sedimentable only when mixed with a mem-
brane fraction (Fig . 7, compare lanes 5 and 8 with lanes 6
and 7 and 9 and 10), and the proportion of Sarlp recruited
to membranes was enhanced by elevated levels of Secl2p
(three- to fivefold, compare Fig . 7, lanes 6 and 7, and lanes
9 and 10) . Recruitmentto themembrane occurred at4°C and
was independent of ATP or GTP (not shown) . Although
membrane association of Sarlp occurred even with mem-
branes that contained the normal low level of Secl2p, this
could reflect some non-specific binding . Purified Sarlp binds
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to soybean phospholipid liposomes (Barlowe, C ., unpub-
lished results) . Thus, at least part of the inhibitory effect of
Secl2p-rich membranes on ER vesicle budding is due to
membrane recruitment and sequestering of soluble Sarlp.
Sarlp is a small GTP-binding protein required for efficient
protein transport from the endoplasmic reticulum to the
Golgi apparatus (Nakano and Muramatsu, 1989 ; Nishikawa
and Nakano, 1991) . The SARI gene was isolated as a multi-
copy suppressor of a thermosensitive mutation in the SEC12
gene which encodes a membrane glycoprotein involved in
the formation ofER-to-Golgi transport vesicles (Nakano and
Muramatsu, 1989 ; Kaiser and Schekman, 1990 ; Rexach and
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Figure 6 . Sarlp requirement for the assembly of ER-
derived transport vesicles . Vesicle formation assays
were carried out in the presence of 470 /g of wild-
type cytosol and additional fractions. (0) no addition;
GAL : 100 lAg control microsomes (YPH500(pCGS-
109)) ; (GAL-SEC12) 100 Fig Secl2p-rich microsomes
(YP500(pCEY5)) ; (WT) 125 hg wild-type cytosol
(RSY607) ; (GAL-SARI) 125 Fig Sarlp-rich cytosol
(YPH500(pANY2-18)) . The efficiency of vesicle re-
leaseforeach reaction was compared to the maximum
obtained when no additional fractions were added
(24%) . The data shown is the average valueof reac
GAL-SEC12
￿
tions performed in triplicate and error bars represent
+ GAL-SARI
￿
the standard deviation .
Schekman, 1991) . These results suggested that Sarlp could
interact with the cytosolic domain ofSecl2p topromote vesi-
cle assembly . This assumption is now confirmed by our ob-
servation that Sarlp becomes limiting in a vesicle budding
reaction when the level of Secl2p is elevated in a competitor
membrane fraction . In addition, Secl2p-rich membranes
bind Sarlp more abundantly than do normal membranes
which have a low level of Secl2p . Independently, Oka et al .
(1991) have shown that Sarlp isolated from transformed yeast
or Escherichia coli suppresses temperature sensitive trans-
port in the ER-Golgi transport reaction reconstituted with
sec12 mutant membranes . Although all these results point to
an interaction between Sarlp and Secl2p, the contact may
not be direct or stable, and additional factors that may not
be rate-limiting could mediate the interaction .
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Figure 7 Secl2p-dependent membrane binding of
Sarlp . Control microsomes (20 jig) (Microsomes
G ; YPH500(pCGS109)) or Secl2p-rich mem-
branes (Microsomes S ; YPH500(pCEY5)) were
treated with trypsin (Trpsin + ; 200 jig/nil, 30
min, 4°C) . After inactivation of the protease,
microsomes were mixed with either reaction
buffer (Sarlp -), 50 1~g of a Sarlp-rich cytosol
(Sarlp C; YPH500(pANY2-18)) or 25 pl of par-
tially purified Sarlp obtained after gel filtration of
this same cytosol (SarlpP) . In thelatter case,BSA
(1 mg/ml) was included to avoid Sarlp proteolysis .
Sarlp-containing fractions were also incubated in
the absence ofmembranes (Microsomes -) . After
a 5-min incubation on ice, the soluble fraction
(MSS) and membrane fraction (MSP) were sepa-
ratedby a 25,000 g centrifugation and theircontent
analyzed bySDS-PAGE and immunoblotting with
anti-Sarlp or anti-Secl2p antibodies .SarlpRequirementfor theFormationofER
to Golgi Transport Vesicles
Apart from SARI, genetic analysis had identified three other
genes, SEC4, YP77, and ARFI, that encode small GTPbind-
ing proteins required for protein transport at different steps
along the secretory pathway (Salminen and Novick, 1987 ;
Segev et al ., 1988 ; Stearns et al ., 1990) . In the case of
Sec4p, localization ofthe protein as well as mutational anal-
ysis suggest that it is required for proper targeting and fusion
of secretory vesicles to the plasma membrane (Goud et al .,
1988 ; Walworth et al., 1989) . Biochemical studies have
shown that ER-to-Golgi transport and cis-to-medial Golgi
transport is inhibited by GTPyS (Malengon et al., 1987 ;
Baker et al ., 1988 ; Ruohola et al ., 1988 ; Beckers and Balch,
1989) and by synthetic peptides corresponding to the effector
domain ofmembers of the rab family ofmammalian Sec4p/
Yptlp-related proteins (Plutner et al., 1990 ; Zaharoui et al .,
1989) . In mammalian cells, GTPyS inhibition results in the
accumulation of intra-Golgi non-clathrin-coated-vesicles
docked to their acceptor compartment (Melangon et al .,
1987 ; Orci et al ., 1989 ; Malhotra et al ., 1989) . In yeast,
Yptlp is required for efficient in vitro ER to Golgi transport
(Baker et al ., 1990 ; Bacon et al ., 1989) and its immobiliza-
tion by Yptlp antibody Fab fragments results in the accumu-
lation of transport vesicles en route to the Golgi (Rexach and
Schekman, 1991) . Bourne (1988) has proposed a unifying
model which suggests that each GTP-binding protein is re-
quired at a specific step to ensure an efficient targeting of
vesicular carriers to their acceptor compartment .
It appears thatGTPyS also inhibits vesicle budding or re-
lease from the trans-Golgi network (Tooze et al ., 1990) and
from the ER (Rexach and Schekman, 1991 ; Wuestehube, L .,
and R . Schekman, manuscript in preparation) . We have
shown that Sarlp is required for vesicle assembly during ER-
Golgi transport and is thus the likely target ofGTPyS inhibi-
tion in this process. A model forthe function ofSarlp in vesi-
cle formation is proposed in Fig . 8 . Together with the
involvement of Yptlp in ER-Golgi transport (Segev et al .,
1988 ; Baker et al ., 1990; Rexach and Schekman, 1991), our
results suggest that Sarlp and Yptlp may function in succes-
sive steps using GTP binding and hydrolysis to facilitate pro-
tein transport from the ER .
Structural differences between Sarlp and Yptlp support the
view that they act at different stages during a single round
of vesicular traffic . Whereas Yptlp is closely related to the
mammalian oncogene ras (Gallwitz et al., 1982), the Sarlp
nucleotide binding site (G-1 and G-3 regions ; Bourne et al .,
1991) is more closely related to the family ofADPribosyla-
tion factors (ARF ; Kahn, 1990 ; Nakano and Muramatsu,
1989 ; Bourne et al., 1991) . ARF is associated with intra-
Golgi transport vesicles inmammalian cells (Serafini et al.,
1990) and its yeast homologue, Arflp, is required for protein
transport and also is localized to the Golgi apparatus (Sewell
and Kahn, 1988 ; Stearns et al ., 1990) . ARF could play a role
similar to that of Sarlp but at a later stage in secretion .
Secl2p-dependent Membrane Attachment ofSarlp
A functional difference between Yptlp and Sarlp is also sug-
gested by different possible mechanisms of membrane at-
tachment . Yptlp, Sec4p, and members of the rub family of
small GTPbinding proteins (Haubrfck et al ., 1987; Touchot
d'Enfert et al . Secl2p and Sarlp Interact to Promote Vesicle Budding
Figure8 . A diagram for the function of Sarlp and Secl2p in the for-
mation of ER-derived vesicles . Attachment of Sarlp (hatched box)
to the membrane is mediated by Secl2p (solid rectangle) . The
blocks imposed by GTRyS and by an excess of Secl2p-enriched
membranes (SEM) in vesicle release are shown.
et al ., 1987; Zahraoui et al ., 1989 ; Chavrier et al ., 1990)
have at least one cysteine that is located near the COOH ter-
minus of the protein . By analogy with the mammalian ras
oncogene (Hancock et al ., 1989), this residue is thought to
be modified by a lipid, possibly a farnesyl analogue, which
mediates membrane attachment (Molenaar et al ., 1988 ;
Walworth et al., 1990) . Sarlp does not have a carboxy-
terminal cysteine nor any site of putative lipid modification
that could explain its strong affinity for membranes (Nishi-
kawa and Nakano, 1991). In this study, we have established
an in vitro assay that measures the binding of Sarlp to ER
membranes . Results presented in Fig. 7 show that Sarlp
membrane attachment is stimulated by elevated levels of
Secl2p. Thus, Sarlp may become membrane bound through
the intervention of Secl2p .
Secl2p could act as a membrane anchor for Sarlp or alter
the conformation of Sarlp so as to expose a hydrophobic sur-
face enabling direct contact with the lipid bilayer. In both
cases, Secl2p-specific membrane attachment of Sarlp could
result in the regulated formation of an ER-Golgi transport
vesicle at specific sites on the ER membrane . Studies with
purified forms of both proteins will distinguish these possi-
bilities .
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